Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy
Hisashi Yokomizo(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Liane J. Tinsley(Joslin Diabetes Center), Jennifer K. Sun(Joslin Diabetes Center), Hillary A. Keenan(Joslin Diabetes Center), Sayaka Katagiri(Joslin Diabetes Center), Edward P. Feener(KalVista Pharmaceuticals (United States)), Sonia L. Hernandez(University of Chicago), Fabrício Simão(Joslin Diabetes Center), I‐Hsien Wu(Joslin Diabetes Center), Lloyd Paul Aiello(Joslin Diabetes Center), Chih‐Hao Wang(Genomics Research Center, Academia Sinica), Robert L. Avery(California Retina Consultants), Yasutaka Maeda(Kyushu University), David Pober(Joslin Diabetes Center), Allen C. Clermont(Joslin Diabetes Center), Atsushi Ishikado(Joslin Diabetes Center), Ward Fickweiler(Joslin Diabetes Center), Qian Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Bei Sun(Yantaishan Hospital), Kyoungmin Park(Joslin Diabetes Center), Samantha M. Paniagua(Joslin Diabetes Center), Timothy S. Kern(Case Western Reserve University)
Cited by 93
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979